Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 40,257,261
- Total 13F value
- $2,228,992,305
- Share change
- -3,048,720
- Put/Call ratio
- 431%
- SEC-reported price per share
- $55.37
- Number of holders
- 192
- Value change
- -$65,425,283
- Number of buys
- 106
- Number of sells
- 77
- Shares outstanding
- 42,282,321
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
192
Top holders
10
TARS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Ownership snapshot
Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cowen Financial Products LLC
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
3/4/5
Lead comparable stake: 4.9%
13D/G row: Cowen Financial Products LLC
Showing 1-6 of 15 holder rows.
Quick read
Cowen Financial Products LLC leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cowen Financial Products LLC's linked filing trail.
Comparable ownership
Top 5
Cowen Financial Products LLC
4.9%
BlackRock, Inc.
8.9%
RTW INVESTMENTS, LP
8.1%
Paradigm Biocapital Advisors LP
5.8%
TANG CAPITAL MANAGEMENT LLC
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cowen Financial Products LLC |
13D/G
|
4.9%
|
$94,926,816
1,909,228 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
8.9%
|
$123,518,528
3,755,504 shares
|
— | 30 Sep 2024 |
| RTW INVESTMENTS, LP |
13F
3/4/5
Company · 10%+ Owner
|
8.1%
|
$112,236,665
3,412,486 shares
|
— | 30 Sep 2024 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
5.8%
|
$80,266,236
2,440,445 shares
|
— | 30 Sep 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
5.3%
|
$74,160,273
2,254,797 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
5.2%
|
$72,640,468
2,208,588 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
192
Shares
40,257,261
Rows available
192
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
161
Q4 2024 holders
192
Holder diff
31
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend